The Global NASH Council in the News

The 6th Annual Liver Connect Meeting of the Chronic Liver Disease Foundation was held from February 26–28, 2026, at the Gaylord Pacific Resort & Convention Center in beautiful San Diego, California. The meeting brought together more than 500 in-person attendees, along with a substantial number of virtual participants from across the country and internationally. The...Continue reading→

The G-MASLD project with 18,759 biopsy-confirmed MASLD patients from 41 countries has been carried out by members of GNC. The project continues to provide critical data about MASLD/MASH and NITs from real world practices. In this analysis of G-MASLD data, the diagnostic accuracy and performance of NITs were influenced by patient characteristics. FIB-4 performance declined...Continue reading→

The Global NASH/MASH Council (GNC) was pleased to collaborate with Qatar Health Congress 2026 to address key topics in MASLD and MASH. The Congress was co-organized under the leadership of Professor Abdel-Naser Elzouki, Chair of the Scientific Committee and a member of the GNC, by the Department of Medicine at Hamad Medical Corporation, in collaboration...Continue reading→

The first Paris International Liver Meeting (PILM 2026) was a highly successful three-day scientific conference held from January 19–21, 2026. The meeting featured outstanding scientific sessions covering key areas including MASLD, MetALD, alcohol-associated liver disease, viral hepatitis, hepatocellular carcinoma, cholestatic liver diseases, and complications of cirrhosis. To watch the highlights from the meeting, please click...Continue reading→

The first Paris International Liver Meeting (PILM 2026) was organized by Professors Laurent Castera and Zobair Younossi, together with the Scientific Committee. This three-day meeting was attended by 722 participants (449 on site and 273 virtual) from 67 countries and was highly successful. Scientific sessions covered key areas including MASLD, MetALD, alcohol-associated liver disease, hepatocellular...Continue reading→

We’re excited to take part in the inaugural Paris International Liver Meeting (PILM), held 19–21 January 2026 at the historic Maison de la Chimie in Paris. PILM 2026 will showcase a robust program featuring global leaders in Steatotic Liver Disease (MASLD/MASH, MetALD, ALD), cholestatic liver disease (PBC, PSC), viral hepatitis, and complications of cirrhosis. Each...Continue reading→

Members of the Global NASH/MASH Council (GNC) have recently published two major original manuscripts in Hepatology. The GNC Collaborators created the Global-MASLD project, a cohort of 17,792 biopsy-proven MASLD cases with extensive clinical, laboratory, non-invasive test (NIT) data, and long-term outcomes. In the first manuscript, “Global Performance of Non-Invasive Tests in MASLD: Insights from the...Continue reading→

This year’s AASLD meeting was a highly productive and engaging event for members of the Global NASH/MASH Council (GNC) and Global Liver Council (GLC). In addition to hosting a successful joint annual GNC/GLC meeting featuring insightful presentations and discussions, members also delivered a total of 18 research presentations, including 4 oral presentations and 14 poster...Continue reading→

Over 100 members of the Global NASH/MASH Council (GNC) and the Global Liver Council (GLC), representing leading hepatology experts from more than 30 countries worldwide, attended the 11th bi-annual GNC/GLC meeting held during AASLD 2025 in Washington, D.C. The meeting commenced with opening remarks from Professor Zobair Younossi, Chair of the GNC/GLC, who highlighted the...Continue reading→

MASH is rapidly emerging as one of the most common causes of chronic liver disease worldwide, yet its economic impact has often been underestimated. The Global NASH/MASH Council (GNC) recently conducted an in-depth analysis of the future burden of MASH across nine countries, including the U.S., Germany, France, UK, Italy, Spain, Japan, Brazil, and Saudi...Continue reading→